Original Query: ALL
Previous Study | Return to List | Next Study

Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00499902
Recruitment Status : Terminated (CO Phase 2 data did not show sufficient improvement in cath opening at higher dose/concentration evaluated. Nuvelo ended further clinical dev of alfimeprase.)
First Posted : July 12, 2007
Last Update Posted : April 24, 2008
Information provided by:
ARCA Biopharma, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : May 2008
  Estimated Study Completion Date : May 2008